Piramal Eyes 20% Pharma Stake Sale

Looking To Raise Funds For Growth Through Acquisitions

Pie_Chart
Piramal is looking to sell a stake of up to a fifth in its pharma business • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Strategy

More from Business